000 | 01927 a2200517 4500 | ||
---|---|---|---|
005 | 20250514194940.0 | ||
264 | 0 | _c20050511 | |
008 | 200505s 0 0 eng d | ||
022 | _a1619-7070 | ||
024 | 7 |
_a10.1007/s00259-004-1631-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKnuuti, Juhani | |
245 | 0 | 0 |
_aAssessment of right ventricular oxidative metabolism by PET in patients with idiopathic dilated cardiomyopathy undergoing cardiac resynchronization therapy. _h[electronic resource] |
260 |
_bEuropean journal of nuclear medicine and molecular imaging _cDec 2004 |
||
300 |
_a1592-8 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
650 | 0 | 4 |
_aAcetates _xpharmacokinetics |
650 | 0 | 4 |
_aCarbon _xpharmacokinetics |
650 | 0 | 4 | _aCardiac Pacing, Artificial |
650 | 0 | 4 |
_aCardiomyopathy, Dilated _xcomplications |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeart Ventricles _xdiagnostic imaging |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOxygen _xmetabolism |
650 | 0 | 4 |
_aPositron-Emission Tomography _xmethods |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aRadiopharmaceuticals _xpharmacokinetics |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVentricular Dysfunction, Right _xdiagnostic imaging |
700 | 1 | _aSundell, Jan | |
700 | 1 | _aNaum, Alexandru | |
700 | 1 | _aEngblom, Erik | |
700 | 1 | _aKoistinen, Juhani | |
700 | 1 | _aYlitalo, Antti | |
700 | 1 | _aStolen, Kira Q | |
700 | 1 | _aKalliokoski, Riikka | |
700 | 1 | _aNekolla, Stephan G | |
700 | 1 | _aBax, K E Jeroen J | |
700 | 1 | _aAiraksinen, K E Juhani | |
773 | 0 |
_tEuropean journal of nuclear medicine and molecular imaging _gvol. 31 _gno. 12 _gp. 1592-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00259-004-1631-9 _zAvailable from publisher's website |
999 |
_c14990912 _d14990912 |